The Paxlovid pills are being developed at Pfizer’s two Irish plants in Ringaskiddy and Newbridge. Picture: Reuters
Pfizer’s new anti-viral drugs for Covid-19 will only be prescribed for “high-risk patients” for now, but may provide benefits to the wider public in time, according to the scientist who developed the treatment. Dr Annaliesa Anderson, the clinical development lead on the Paxlovid antiviral programme, was speaking to the Business Post from New Jersey in the US.Subscribe from just €1 for the first month!
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
New bill may push more legal costs on those who take insurers to court | Business PostRobert Troy: ‘If someone wants to reject their award and bring it to court and the court doesn’t increase the award any further, well then, they're going to have to pay for that’ obraonain now this is a good thing and will help
Sumber: businessposthq - 🏆 8. / 71 Baca lebih lajut »
Ronan to make new play for Dublin portfolio after legal case dropped | Business PostDeveloper may be seeking a new partner to bid for three landmark properties after ongoing dispute with US group Fortress is resolved out of court
Sumber: businessposthq - 🏆 8. / 71 Baca lebih lajut »
ESB’s new gas power contracts triple in value | Business PostWhistleblower has accused semi-state of abusing market position and ‘lowballing’ offers in earlier auctions
Sumber: businessposthq - 🏆 8. / 71 Baca lebih lajut »